These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33450448)

  • 1. Targeted next generation sequencing directly from sputum for comprehensive genetic information on drug resistant Mycobacterium tuberculosis.
    Kambli P; Ajbani K; Kazi M; Sadani M; Naik S; Shetty A; Tornheim JA; Singh H; Rodrigues C
    Tuberculosis (Edinb); 2021 Mar; 127():102051. PubMed ID: 33450448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of targeted next-generation sequencing and the Xpert MTB/RIF assay for detection of
    Zhang H; Dai X; Hu P; Tian L; Li C; Ding B; Yang X; He X
    Microbiol Spectr; 2024 May; 12(5):e0409823. PubMed ID: 38602399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted next-generation sequencing of
    Uddin MKM; Cabibbe AM; Nasrin R; Ghodousi A; Nobel FA; Rahman SMM; Ahmed S; Ather MF; Razzaque SMA; Raihan MA; Modak PK; Berland JL; Gemert WV; Mohsin SMI; Cirillo DM; Banu S
    Emerg Microbes Infect; 2024 Dec; 13(1):2392656. PubMed ID: 39136526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanopore-based targeted sequencing test for direct tuberculosis identification, genotyping, and detection of drug resistance mutations: a side-by-side comparison of targeted next-generation sequencing technologies.
    Cabibbe AM; Moghaddasi K; Batignani V; Morgan GSK; Di Marco F; Cirillo DM
    J Clin Microbiol; 2024 Oct; 62(10):e0081524. PubMed ID: 39240079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole genome enrichment approach for rapid detection of Mycobacterium tuberculosis and drug resistance-associated mutations from direct sputum sequencing.
    Soundararajan L; Kambli P; Priyadarshini S; Let B; Murugan S; Iravatham C; Tornheim JA; Rodrigues C; Gupta R; Ramprasad VL
    Tuberculosis (Edinb); 2020 Mar; 121():101915. PubMed ID: 32279871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Assessment of a Novel Whole-Gene-Based Targeted Next-Generation Sequencing Assay for Detecting the Susceptibility of Mycobacterium tuberculosis to 14 Drugs.
    Wu SH; Xiao YX; Hsiao HC; Jou R
    Microbiol Spectr; 2022 Dec; 10(6):e0260522. PubMed ID: 36255328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid identification of a Mycobacterium tuberculosis full genetic drug resistance profile through whole genome sequencing directly from sputum.
    Nimmo C; Doyle R; Burgess C; Williams R; Gorton R; McHugh TD; Brown M; Morris-Jones S; Booth H; Breuer J
    Int J Infect Dis; 2017 Sep; 62():44-46. PubMed ID: 28716462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    Xie YL; Chakravorty S; Armstrong DT; Hall SL; Via LE; Song T; Yuan X; Mo X; Zhu H; Xu P; Gao Q; Lee M; Lee J; Smith LE; Chen RY; Joh JS; Cho Y; Liu X; Ruan X; Liang L; Dharan N; Cho SN; Barry CE; Ellner JJ; Dorman SE; Alland D
    N Engl J Med; 2017 Sep; 377(11):1043-1054. PubMed ID: 28902596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel automatic molecular test for detection of multidrug resistance tuberculosis in sputum specimen: A case control study.
    Li Q; Ou XC; Pang Y; Xia H; Huang HR; Zhao B; Wang SF; Zhao YL
    Tuberculosis (Edinb); 2017 Jul; 105():9-12. PubMed ID: 28610793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis.
    Rufai SB; Kumar P; Singh A; Prajapati S; Balooni V; Singh S
    J Clin Microbiol; 2014 Jun; 52(6):1846-52. PubMed ID: 24648554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR.
    Ruiz M; Torres MJ; Llanos AC; Arroyo A; Palomares JC; Aznar J
    J Clin Microbiol; 2004 Apr; 42(4):1585-9. PubMed ID: 15071008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.
    Boehme CC; Nicol MP; Nabeta P; Michael JS; Gotuzzo E; Tahirli R; Gler MT; Blakemore R; Worodria W; Gray C; Huang L; Caceres T; Mehdiyev R; Raymond L; Whitelaw A; Sagadevan K; Alexander H; Albert H; Cobelens F; Cox H; Alland D; Perkins MD
    Lancet; 2011 Apr; 377(9776):1495-505. PubMed ID: 21507477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the Xpert(®) MTB/RIF and GenoType(®) MTBDRplus assays in Georgia.
    Bablishvili N; Tukvadze N; Avaliani Z; Blumberg HM; Kempker RR
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):676-8. PubMed ID: 25946358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing.
    Doyle RM; Burgess C; Williams R; Gorton R; Booth H; Brown J; Bryant JM; Chan J; Creer D; Holdstock J; Kunst H; Lozewicz S; Platt G; Romero EY; Speight G; Tiberi S; Abubakar I; Lipman M; McHugh TD; Breuer J
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29848567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.
    Luetkemeyer AF; Firnhaber C; Kendall MA; Wu X; Mazurek GH; Benator DA; Arduino R; Fernandez M; Guy E; Johnson P; Metchock B; Sattler F; Telzak E; Wang YF; Weiner M; Swindells S; Sanne IM; Havlir DV; Grinsztejn B; Alland D;
    Clin Infect Dis; 2016 May; 62(9):1081-8. PubMed ID: 26839383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redefining MTBDRplus test results: what do indeterminate results actually mean?
    Nikam C; Patel R; Sadani M; Ajbani K; Kazi M; Soman R; Shetty A; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):154-9. PubMed ID: 26792465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrosequencing for rapid detection of tuberculosis resistance in clinical isolates and sputum samples from re-treatment pulmonary tuberculosis patients.
    Zheng R; Zhu C; Guo Q; Qin L; Wang J; Lu J; Cui H; Cui Z; Ge B; Liu J; Hu Z
    BMC Infect Dis; 2014 Apr; 14():200. PubMed ID: 24725975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct detection of drug-resistant
    Murphy SG; Smith C; Lapierre P; Shea J; Patel K; Halse TA; Dickinson M; Escuyer V; Rowlinson MC; Musser KA
    Front Public Health; 2023; 11():1206056. PubMed ID: 37457262
    [No Abstract]   [Full Text] [Related]  

  • 20. Xpert MTB/XDR: a 10-Color Reflex Assay Suitable for Point-of-Care Settings To Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive Sputum.
    Cao Y; Parmar H; Gaur RL; Lieu D; Raghunath S; Via N; Battaglia S; Cirillo DM; Denkinger C; Georghiou S; Kwiatkowski R; Persing D; Alland D; Chakravorty S
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33298611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.